Comprehensive US stock backtesting and historical performance analysis to validate investment strategies before committing capital. We provide extensive historical data that allows you to test any trading idea before risking real money.
As of 2026-04-13, Omnicell Inc. (OMCL), a provider of pharmacy and clinical workflow automation solutions for healthcare facilities, is trading at $34.99, marking a 1.72% gain on the day. This analysis evaluates recent price action, sector context, and key technical levels for the stock, as investors weigh broader market trends against company-specific dynamics. No recent earnings data is available for OMCL as of this writing, so recent price moves have been driven primarily by sector flows and
Is Omnicell (OMCL) Stock Trending Down | Price at $34.99, Up 1.72% - ATR Levels
OMCL - Stock Analysis
3288 Comments
1711 Likes
1
Brant
Engaged Reader
2 hours ago
Clear and concise analysis β appreciated!
π 240
Reply
2
Jeweldene
Senior Contributor
5 hours ago
I agree, but donβt ask me why.
π 195
Reply
3
Cecilio
Returning User
1 day ago
Expert US stock short interest and short squeeze potential analysis for identifying high-risk high-reward opportunities. Our short interest data helps you understand bearish sentiment and potential catalysts for short covering rallies.
π 66
Reply
4
Chee
Expert Member
1 day ago
Iβd high-five you, if I could reach through the screen. ποΈ
π 207
Reply
5
Lizandro
New Visitor
2 days ago
Truly a master at work.
π 36
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.